Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin Rural Emergency Hospitals — Transformative Change or Limited Impact? [PODCAST] - (Posted On Wednesday, March 22, 2023) Recent Developments to the 340B Drug Pricing Program [PODCAST] - (Posted On Thursday, December 15, 2022) New Data Available Under the Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, November 17, 2022) Genesis Healthcare and the 340B Program Patient Definition [PODCAST] - (Posted On Tuesday, August 09, 2022) Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next - (Posted On Tuesday, June 21, 2022) Medicare Reimbursement for Community Hospital Residency Programs [PODCAST] - (Posted On Monday, January 31, 2022) 2022 OPPS Final Rule Overview: CMS Finalizes Policies on 340B, Hospital Price Transparency, and Inpatient-Only List - (Posted On Monday, November 08, 2021) An Update on the CMS Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, October 21, 2021) CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance - (Posted On Thursday, July 22, 2021) 340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case - (Posted On Thursday, July 08, 2021) Pagination Page 1 Next page Next › Current Legal Analysis China’s National Intellectual Property Administration Releases Statistical Data on Patent Licensing from 2019 – 2023 by: Aaron Wininger FTC Approves Final Order Against Seller of AI “Testimonial & Review” Service for Allegedly Providing Subscribers with Means to Generate Deceptive Reviews by: Richard B. Newman Cook County Employers: Time To Update Your Paid Leave Policies by: Alison B. Crane , Sarah J. Gasperini FTC Scrutinizing Healthcare Lead Generators and Marketers as Open Enrollment Begins by: Richard B. Newman Beltway Buzz, December 20, 2024 by: James J. Plunkett Final Regulations Released for Partnership Recourse Liabilities by: Kenneth C. Wang , Jared C. Kassan EPA Finalizes TSCA Risk Management Rules for PCE and TCE by: Mark N. Duvall , Ryan J. Carra The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges by: Adam Herbst Upcoming Events Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
